BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UIC
BEGIN:VEVENT
UID:2026031502262420250627T11000020250627T12000069b618d05ef7d@uic.edu
CATEGORIES:MEETING
STATUS:TENTATIVE
DTSTAMP:20250313T085412
DTSTART:20250627T110000
DTEND:20250627T120000
SUMMARY:Mary E. Hartnett, PhD (Stanford University): "Extending Developmental Retinal Angiogenesis to Treat Retinopathy of Prematurity"
DESCRIPTION:Host: Jan Kitajewski, PhD    Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide and is increasing in prevalence. The pathophysiology has evolved over 50+ years with advancements to increase survival of infants of extreme prematurity. In addition, retinal treatments for blinding ROP have changed from destroying peripheral avascular retina to regulating angiogenic signaling to reduce pathologic angiogenesis. Our lab has sought to improve developmental angiogenesis to support retinal development and vision of the premature infant and reduce the stimulus for pathologic, hypoxia-driven pathologic angiogenesis. We discovered that regulating signaling through vascular endothelial growth factor (VEGF) receptors extends normal developmental angiogenesis and reduces pathologic angiogenesis. This talk will discuss our work on VEGF signaling and new avenues. | Event post: https://chicago.medicine.uic.edu/physiology/events?page_id=1992
LOCATION:Moss Auditorium - 1020 COMRB    Select 
CLASS:PRIVATE
END:VEVENT
END:VCALENDAR